EUVIMEDEUVIMED entdecken
Crossref

Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasiexperimental Study of High- Versus Low-Adoption States

Yongmei Huang, Stephanie J Chan iD, Jason D Wright, Jennifer H Kuo iD, Catherine M McManus, James A Lee, Eric J Kuo iD

Thyroid® · 2024-03 · 34 (3) · 388-398

DOI: 10.1089/thy.2023.0651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thyroid®, online erschienen am 22.01.2024. Verfasst von Yongmei Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Columbia University, New York, New York, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Nodule. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Over the last decade, the utilization of molecular testing (MT) for the evaluation of thyroid nodules has increased. Rates and patterns of adoption of MT and its effect on thyroidectomy rates nationally are unknown. Varying rates of MT adoption at the state level provide an opportunity to study the effects of MT on thyroidectomy rates using a quasiexperimental study design.

Methods

We performed a retrospective analysis of American adult patients in the Merative™ MarketScan ® Research Databases who underwent thyroid fine-needle aspiration (FNA) from 2011 to 2021. MT included commercially available DNA and RNA platforms and traditional targeted mutational analysis. Interrupted time series analysis was used to evaluate the inflection of MT adoption and thyroidectomy rates after 2015. Difference-in-differences (DID) analysis was used to causally analyze the effect of MT adoption on thyroidectomy rates in high-adoption (at least a 10% increase in MT utilization) versus low-adoption states (no more than 5% increase in MT utilization) from 2015 to 2021.

Results

We identified 471,364 patients who underwent thyroid FNA. The utilization of MT increased over the study period from 0.01% [confidence interval, CI: 0.00% to 0.02%] to 10.1% [CI: 9.7% to 10.5%], in 2021, with an immediate (β2 = 1.61, p = 0.002) and deeper (β3 = 0.6, p < 0.001) increase in MT adoption after 2015. Utilization of MT was lower in black patients, the elderly, rural areas, and patients with Medicaid ( p < 0.05). Thyroidectomy rates were inversely correlated with MT utilization ( r = −0.98, p < 0.0001). From 2015 to 2021, the average MT utilization rate increased from 2.4% to 15.3% in high-adoption states and 1.6% to 5.6% in low-adoption states. In low-adoption states, thyroidectomy rates decreased more but to similar levels (18.5–13.2%) compared with high-adoption states (15.9–13.4%) with an adjusted DID rate of −3.3% [CI −5.6% to −0.8%].

Conclusions

The acceleration in adoption of MT after 2015 likely coincides with the publication of American Thyroid Association guidelines. Black, elderly, and rural patients are less likely to receive MT. Although thyroidectomy rates were inversely correlated with MT utilization, our study suggests that this correlation is not causal. The effect of MT on thyroidectomy rates may be overshadowed by decreasing aggressiveness of thyroid nodule evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroid NoduleAdultHumansAgedThyroidectomyRetrospective StudiesMolecular Diagnostic Techniques

Stichwörter der Autor:innen

molecular testingthyroid nodulesthyroidectomy

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Columbia University, New York, New York, USA.
  • Department of Surgery, Division of GI/Endocrine Surgery, Columbia University, New York, New York, USA.
  • Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA.

ORCID-Profile: Stephanie J Chan, Jennifer H Kuo, Eric J Kuo

Zitieren

APA

Huang, Y., Chan, S. J., Wright, J. D., Kuo, J. H., McManus, C. M., Lee, J. A., & Kuo, E. J. (2024). Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasiexperimental Study of High- Versus Low-Adoption States. Thyroid®, 34(3), 388-398. https://doi.org/10.1089/thy.2023.0651

Vancouver

Huang Y, Chan SJ, Wright JD, Kuo JH, McManus CM, Lee JA, et al. Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasiexperimental Study of High- Versus Low-Adoption States. Thyroid®. 2024;34(3):388-398. doi:10.1089/thy.2023.0651

BibTeX
@article{Huang2024,
  author = {Huang, Yongmei and Chan, Stephanie J and Wright, Jason D and Kuo, Jennifer H and McManus, Catherine M and Lee, James A and Kuo, Eric J},
  title = {Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasiexperimental Study of High- Versus Low-Adoption States},
  journal = {Thyroid®},
  year = {2024},
  volume = {34},
  number = {3},
  pages = {388--398},
  doi = {10.1089/thy.2023.0651}
}
Kostenlos starten →